ABBV Q1 FY2026: $15.0B revenue, +12.4% YoY — QuarterCharts — QuarterCharts United States

QuarterCharts

Free financial-data visualization for US-listed equities. Sankey diagrams, multi-statement charts, and SEC-sourced fundamentals for every public ticker.

Coverage: ~11,250 US-listed equities on NYSE + NASDAQ + NYSEAMERICAN + NYSEARCA, including ETFs, ADRs, REITs, MLPs, and BDCs. See full breakdown.

Not investment advice. QuarterCharts is not a registered investment adviser. Nothing on this site is intended as personalized investment advice. Always consult a licensed financial professional before making investment decisions.

Product

Charts
Sankey
Profile
Earnings Calendar
Global Hub
API
AI Agents (MCP)
Dashboard

Trust & Legal

About
Coverage
Privacy Policy
Terms of Service
Status
Trademarks
Do Not Sell or Share My Personal Information
Accessibility
Open-source attributions
Contact

Company logos shown on QuarterCharts are trademarks of their respective owners and are used solely for identification of the company whose data is displayed. Their use does not imply endorsement, sponsorship, or affiliation with the trademark owners. Full trademarks policy.

Data sourced from SEC EDGAR, and Finnhub. QuarterCharts is not affiliated with SEC or any issuer.

© 2026 TRUE WOOD LLC. All rights reserved.

ABBV Q1 FY2026: $15.0B revenue, +12.4% YoY — QuarterCharts — QuarterCharts United States

⌘K

⌘K

AbbVie Inc.ABBVABBV·Valuation

Charts Sankey Profile Earnings Watchlist

Income Cash Flow Balance Profitability Valuation Capital Growth Risk

«

»

All Earnings Multiples Sales Multiples Book Multiples Cash Flow Multiples Enterprise Value Yields Intrinsic Value

«

»

All
Earnings Multiples
Sales Multiples
Book Multiples
Cash Flow Multiples
Enterprise Value
Yields
Intrinsic Value

Pro: full historyPro: full historyPro: full historyPro: full history

Q1 2024

Q1 2026

Key Metrics for AbbVie Inc.

Annual cadence only — quarterly Key Metrics ship in v2. Date range pills map to annual periods.

Earnings Multiples

Valuation Multiples

Loading chart data, please wait.

P/E Ratio

+34.72%(FY25 vs FY24)

Loading chart data, please wait.

EPS (Diluted)

-$0.03-1.22%(FY25 vs FY24)

Loading chart data, please wait.

Sales Multiples

P/S Ratio

+22.58%(FY25 vs FY24)

Loading chart data, please wait.

Book Multiples

Cash Flow Multiples

Enterprise Value

Yields

Intrinsic Value

Other metrics

Period

Columns

P/E Ratio

+34.72%(FY25 vs FY24)

Loading chart data, please wait.

EPS (Diluted)

-$0.03-1.22%(FY25 vs FY24)

Loading chart data, please wait.

P/S Ratio

+22.58%(FY25 vs FY24)

Loading chart data, please wait.